Granules India Krishnamohan B resigns as Vice President & Head- IT
DMC Registrar Resigns After Govt Threatens Dissolution of Council
Hyderabad: Granules India, a vertically integrated Indian pharmaceutical company, has announced the resignation of Krishnamohan B. from the position of Vice President & Head- IT for better job prospects.
"Krishnamohan B., shall cease to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Vice President & Head- IT with effect from the closure of business hours of June 02, 2025," the Company informed in a BSE filing.
This marks the latest in a series of high-level exits from the company. Earlier this year, G. N. Prashanth, Senior Vice President – Corporate Quality, resigned due to personal reasons, a move reported by Medical Dialogues in April 2025.
Additionally, in March, Sethu Madhavan Sankaran stepped down from his position as Senior Vice President & Head- API Manufacturing & Operations, followed by the resignation of Riaz Ahmed as Senior Vice President & Head- Supply Chain Management in February.
Read also: Granules India G N Prashanth resigns as Senior Vice President - Corporate Quality
Granules India Limited, incorporated in 1991 is a vertically integrated fast growing Indian pharmaceutical company headquartered at Hyderabad with best-in-class facilities and commitment to operational excellence, quality, and customer service. Granules is among the few pharmaceutical companies in the world to be present in the manufacturing of entire value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). Granules products are being distributed to over 300+ customers in regulated and semi-regulated markets with a global presence extending to over 80+ countries with offices across India, US, and UK. The Company has 10 manufacturing facilities out of which 8 are in India and 2 in the USA and has regulatory approvals from US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.
Read also: Granules India appoints Dr PN Baskaran as President - Head API Manufacturing, Operations
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.